• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER; PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER; PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number 2AF284
Device Problem Insufficient Information (3190)
Patient Problems Atrial Fibrillation (1729); Atrial Flutter (1730); Cardiac Arrest (1762); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 03/10/2014
Event Type  Injury  
Event Description
Information received by medtronic indicated that, during a cryoablation procedure, there was a possible perforation of a cardiac structure resulting in cardiac tamponade.The patient was in atrial fibrillation for the duration of the procedure.The physician gained transseptal access per his routine protocol and the devices were placed in the left atrium.The physician performed 2 ablations in the inferior aspect of the lcpv, 2 ablations in the superior aspect of the lcpv, 2 ablations in the ripv, 2 ablations in the rspv.The patient was alternating between what appeared to be atrial fibrillation and left sided atrial flutter.The decision was made to cardiovert the patient to normal sinus rhythm in order to assess for pulmonary vein potentials.The cryoablation catheter and mapping catheter were pulled back inside of the sheath (confirmed by fluoroscopy), and the patient was cardioverted to normal sinus rhythm.Anesthesia noted the blood pressure to be low (30's systolic) immediately upon cardioversion whereas it had been in the 60's or 70's prior to that point.Chest compressions began and it was noted that the blood pressure was elevated to the 50's as a result of the compressions.An effusion/cardiac tamponade was suspected and a pericardiocentesis tray was opened.Surgery was notified.A pericardiocentesis was performed and no blood was able to be aspirated although an effusion was noted on tee.The ct surgeon performed a sub xyphoid window and placed a drain in the pericardium.It was noted that the drain was drawing off a large volume of blood and the decision was made to put the patient on cardiopulmonary bypass in order to perform a sternotomy allowing surgeon better access to the cardiac structures suspected of perforation (left sided pulmonary vein).As of the day after the complication, the patient was stable and recovering.Device 2 of 3, reference mfr report: 3002648230-2014-00054 and 3007798852-2014-00005.
 
Manufacturer Narrative
Bin files showed that at least 15 injections were performed with the cryoablation catheter.Failure files did not show any system notices for the date of event.The device is not available for investigation; it was discarded after the procedure.There was no indication of product malfunction.An internal capa has been initiated to investigate the risk of cardiac perforation, pericardial effusion and tamponade associated with cryoablation for atrial fibrillation.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTIC FRONT ADVANCE CARDIAC CRYOABLATION CATHETER
Type of Device
PERCUTANEOUS CATHETER INTENDED FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
MEDTRONIC CRYOCATH LP
16771 chemin ste-marie
kirkland,qc H9H 5 H3
CA  H9H 5H3
Manufacturer (Section G)
MEDTRONIC CRYOCATH LP
16771 chemin ste-marie
kirkland,qc H9H 5 H3
CA   H9H 5H3
Manufacturer Contact
voula radiotis
16771 chemin ste-marie
kirkland,qc H9H 5-H3
CA   H9H 5H3
5146941212
MDR Report Key3716261
MDR Text Key15114066
Report Number3002648230-2014-00055
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100010/S015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative,company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/10/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/01/2015
Device Model Number2AF284
Device Catalogue Number2AF284
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/10/2014
Initial Date FDA Received04/01/2014
Supplement Dates Manufacturer Received03/10/2014
Supplement Dates FDA Received09/14/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/21/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FLEXCATH ADVANCE 4FC12, ACHIEVE 990063-020
Patient Outcome(s) Required Intervention;
Patient Age00069 YR
Patient Weight79
-
-